Oxford Pre-cancerous Lymphoproliferative Disorders Study

Active, not recruitingOBSERVATIONAL
Enrollment

574

Participants

Timeline

Start Date

July 3, 2019

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Pre-cancerous Lymphoproliferative Disorders
Trial Locations (17)

Unknown

Royal Bournemouth Hospital, Bournemouth

Russells Hall Hospital, Dudley

James Paget Hospital, Great Yarmouth

Leicester Royal Infirmary, Leicester

Clatterbridge Cancer Centre, Liverpool

Epsom Hospital, London

King's College Hospital, London

St George's Hospital, London

Northern Centre for Cancer Care, Newcastle

North Tyneside General Hospital, North Shields

Queens Medical Centre, Nottingham

Derriford Hospital, Plymouth

Poole Hospital, Poole

South Tyneside District Hospital, South Shields

Sunderland Royal Hospital, Sunderland

Musgrove Park Hospital, Taunton

OX3 7LE

Churchill Hospital, Oxford University Hospitals Trust, Oxford

All Listed Sponsors
collaborator

Janssen Research & Development, LLC

INDUSTRY

lead

University of Oxford

OTHER

NCT04023747 - Oxford Pre-cancerous Lymphoproliferative Disorders Study | Biotech Hunter | Biotech Hunter